PX Pulse: Consumer Perspectives on Patient Experience in the U.S. – July 2023
We are pleased to share results from the 13th edition of our PX Pulse survey. Conducted in partnership with Ipsos, PX Pulse captures healthcare consumer perspectives of patient experience in the United States.
The latest release of PX Pulse reveals affordability and access to hospitals and treatments continue as important issues to consumers. While the basic deliverables of quality and overall experience slipped from last quarter, trust in healthcare services remains high, calling for a continued focus on building relationships with patients, families and communities.
Related content
-
Infrastructure & Governance | Policy & Measurement
A Global Perspective on Experience Excellence: Examples from Around the World
7pm EEST (Latvia) | 12pm ET / 11am CT / 10am MT / 9am PT (USA) – Join Vita Steina to learn more about her Fellow in Human Experience (FHX) project to explore and gather a collection of leading practices driving experience excellence globally. Vita’s project provided a comprehensive look at how organizations around the
Learn more -
Innovation & Technology | Policy & Measurement
Using Narrative to Illuminate and Improve Experience
Watch this webinar for an interactive discussion through a series of five mini-case studies to illustrate the power of narrative. The case studies will focus on: (1) using an innovative digital tool to collect patient-generated contextual information and embedding at-a-glance summaries of patient narratives in the EHR (2) mining open-ended comments in experience surveys, with
Learn more -
Patient Family & Community Engagement | Quality & Clinical Excellence
Transforming Lives: A Journey of Compassion and Advocacy
On the Road with the Cystic Fibrosis Foundation – February 2024 by Stacy Palmer, CPXP I recently had the opportunity to travel to Bethesda, Maryland to meet with the Cystic Fibrosis Foundation, a non-profit organization dedicated to supporting individuals with cystic fibrosis (CF) by funding research and drug development, partnering with the CF community, advancing
Learn more